Avanos Medical, Inc. (AVNS) earnings
AVNS earnings moved a median of -0.18% by the close. Quarterly and annual AVNS reports and results, each read against the price at its own news timestamp. Back to the AVNS overview →
26 measured AVNS earnings events.
Where these AVNS earnings landedvs 26 measured AVNS earnings reactions
| Middle 50% of AVNS earnings reactions | -1.63% to +2.68% |
|---|---|
| Median reaction (to close) | -0.18% |
| Measured reactions | 26 |
Point-in-time · zero look-ahead
Half of the 26 AVNS earnings events with a measured close landed between -1.63% and +2.68%; 46% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Avanos Medical, Inc. Announces First Quarter 2026 Results | Press release | -0.06% | +0.00% | |
| Form 10-Q AVANOS MEDICAL, INC. For: Mar 31 | SEC filing · Form 10-Q | +0.12% | +0.04% | |
| Form 10-K AVANOS MEDICAL, INC. For: Dec 31 | SEC filing · Form 10-K | +0.95% | +5.12% | |
| Avanos Medical, Inc. Announces Third Quarter 2025 Results | Press release | -2.26% | -14.03% | |
| Form 10-Q AVANOS MEDICAL, INC. For: Sep 30 | SEC filing · Form 10-Q | +2.28% | +4.19% | |
| Avanos Medical, Inc. to Webcast Conference Call Discussing Third Quarter 2025 Financial Results | Press release | -0.74% | -3.46% | |
| Avanos Medical, Inc. Announces Second Quarter 2025 Results | Press release | -4.86% | -9.35% | |
| Form 10-Q AVANOS MEDICAL, INC. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +4.34% | |
| Avanos Medical, Inc. to Webcast Conference Call Discussing Second Quarter 2025 Financial Results | Press release | +0.17% | -0.75% | |
| Avanos Medical, Inc. Announces First Quarter 2025 Results | Press release | +1.59% | +2.47% | |
| Form 10-Q AVANOS MEDICAL, INC. For: Mar 31 | SEC filing · Form 10-Q | +0.16% | -2.02% | |
| Avanos Medical, Inc. to Webcast Conference Call Discussing First Quarter 2025 Financial Results | Press release | +0.73% | +2.75% | |
| Form 10-K AVANOS MEDICAL, INC. For: Dec 31 | SEC filing · Form 10-K | +0.98% | -0.98% | |
| Avanos Medical, Inc. Announces Third Quarter 2024 Results, retirement of CEO | Press release | +8.07% | -2.26% | |
| Form 10-Q AVANOS MEDICAL, INC. For: Sep 30 | SEC filing · Form 10-Q | -0.56% | -0.43% | |
| Avanos Medical, Inc. to Webcast Conference Call Discussing Third Quarter 2024 Financial Results | Press release | +0.36% | +0.31% | |
| Avanos Medical, Inc. Announces Second Quarter 2024 Results | Press release | -2.47% | +2.00% | |
| Form 10-Q AVANOS MEDICAL, INC. For: Jun 30 | SEC filing · Form 10-Q | +0.14% | -2.21% | |
| Avanos Medical, Inc. to Webcast Conference Call Discussing Second Quarter 2024 Financial Results | Press release | +0.09% | +1.19% | |
| Avanos Medical, Inc. Announces First Quarter 2024 Results | Press release | +1.59% | +2.76% | |
| Form 10-Q AVANOS MEDICAL, INC. For: Mar 31 | SEC filing · Form 10-Q | -0.33% | -1.30% | |
| Avanos Medical, Inc. to Webcast Conference Call Discussing First Quarter 2024 Financial Results | Press release | — | -1.54% | |
| Form 10-K AVANOS MEDICAL, INC. For: Dec 31 | SEC filing · Form 10-K | -1.40% | -0.36% | |
| Avanos Medical, Inc. Announces Third Quarter 2023 Results | Press release | +1.20% | +10.88% | |
| Form 10-Q AVANOS MEDICAL, INC. For: Sep 30 | SEC filing · Form 10-Q | -0.92% | +4.16% | |
| Avanos Medical, Inc. to Webcast Conference Call Discussing Third Quarter 2023 Financial Results | Press release | — | -1.66% |
Keep exploring
More AVNS: analyst actions → · SEC filings → · AVNS overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| NOVUS THERAPEUTICS (NVUS) | 263 | -0.14% | 40% |
| Haemonetics Corporation (HAE) | 261 | -0.07% | 44% |
| Enanta Pharmaceuticals, Inc. (ENTA) | 257 | +0.06% | 50% |
| FORTY SEVEN (FTSV) | 257 | +0.01% | 51% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.